Q32 Bio Inc [NASDAQ: QTTB] stock went on an upward path that rose over 119.87% on Thursday, amounting to a one-week price increase of more than 130.56%.
Over the last 12 months, QTTB stock dropped by -3.49%. The one-year Q32 Bio Inc stock forecast points to a potential upside of 77.87. The average equity rating for QTTB stock is currently 2.00, trading closer to a bullish pattern in the stock market.
The market cap for the stock reached $40.50 million, with 12.20 million shares outstanding and 4.44 million shares in the current float. Compared to the average trading volume of 148.13K shares, QTTB stock reached a trading volume of 58854086 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Guru’s Opinion on Q32 Bio Inc [QTTB]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for QTTB shares is $15.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on QTTB stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Piper Sandler have made an estimate for Q32 Bio Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on February 11, 2025. While these analysts kept the previous recommendation, BMO Capital Markets raised their target price from $22 to $3. The new note on the price target was released on February 11, 2025, representing the official price target for Q32 Bio Inc stock. Previously, the target price had yet another drop from $95 to $16, while Wells Fargo kept a Equal Weight rating on QTTB stock. On December 11, 2024, analysts decreased their price target for QTTB shares from 90 to 22.
QTTB Stock Performance Analysis:
Q32 Bio Inc [QTTB] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 130.56. With this latest performance, QTTB shares gained by 82.42% in over the last four-week period, additionally sinking by -9.29% over the last 6 months – not to mention a drop of -3.49% in the past year of trading.
Insight into Q32 Bio Inc Fundamentals:
Return on Equity for this stock declined to -51.68%, with Return on Assets sitting at -51.68%.
QTTB Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for QTTB. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Q32 Bio Inc go to 4.80%.
Q32 Bio Inc [QTTB] Institutonal Ownership Details
There are presently around $73.27%, or 78.42% of QTTB stock, in the hands of institutional investors. The top three institutional holders of QTTB stocks are: ORBIMED ADVISORS LLC with ownership of 2.25 million shares, which is approximately 18.831%. ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, holding 2.09 million shares of the stock with an approximate value of $$37.55 million in QTTB stocks shares; and ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC, currently with $$19.2 million in QTTB stock with ownership which is approximately 9.217%.
